According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Eidos Therapeutics CEO bought 1,000,000 shares
Eidos Therapeutics Inc. (EIDX, Financial) CEO and 10% Owner Neil Kumar bought 1 million shares on June 22 at a price of $17.00. The price of the stock has increased by 19.65% since.
Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. The company has a market cap of $747.24 million. Its shares traded at $20.34 as of June 29.
On June 22, the company announced the closing of its initial public offering of 7,187,500 shares of common stock at a public offering price of $17.00 per share.
Director Rajeev M. Shah bought 1,058,824 shares on June 22 at a price of $17. The price of the stock has increased by 19.65% since.
Director and 10% Owner Ali J. Satvat bought 1 million shares on June 22 at a price of $17. The price of the stock has increased by 19.65% since.
10% Owner Capital Healthcare Fund LP RA bought 1,058,824 shares on June 22 at a of $17. The price of the stock has increased by 19.65% since.
10% Owner Pharma LLC Bridgebio bought 1 million shares on June 22 at a price of $17. The price of the stock has increased by 19.65% since.
Marriott Vacations Worldwide CEO bought 3,500 shares
Marriott Vacations Worldwide Corp. (VAC, Financial) President and CEO Stephen P. Weisz bought 3,500 shares on June 28 at a price of $108.43. The price of the stock has increased by 3.74% since.
Marriott Vacations Worldwide is an owner of holiday resorts primarily in the United States. Its portfolio of properties includes Marriott Vacation Club, Grand Residencies and The Ritz-Carlton Destination Club. The company has a market cap of $3.00 billion. Its shares traded at $112.48 with a price-earnings ratio of 13.26 as of June 29.
Net income for the first quarter of 2018 was $36 million compared to net income of $28 million in the first quarter of 2017.
Weisz also bought 4,058 shares on June 15 at the average price of $117.86. The price of the stock has decreased by 4.56% since.
OPKO Health CEO bought 70,000 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman, and 10% Owner Phillip Frost bought 70,000 shares during the past week at an average price of $4.60.
OPKO Health is a diversified health care company that seeks to establish industry-leading positions in large, rapidly growing markets. The company has a market cap of $2.63 billion. Its shares traded at $4.79 as of June 29.
Net loss for the first quarter of 2018 was $43.1 million compared to a net loss of $34.5 million for the comparable period of 2017.
Frost bought 20,000 shares on June 19 at a price of $4.32; 30,000 shares on June 21 at a price of $4.54; 10,000 shares on June 22 at a price of $4.45; 10,000 shares on June 27 at a price of $4.75; and 20,000 shares on June 28 at a price of $4.68. The price of the stock has increased by 2.35% since.
Aptinyx CEO bought 2,400 shares
Aptinyx Inc. (APTX, Financial) CEO and President Norbert G. Riedel bought 2,400 shares on June 25 at a price of $16.00. The price of the stock has increased by 26.38% since.
Aptinyx is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. The company has a market cap of $786.4 million. Its shares traded at $20.22 as of June 29.
On June 25, 2018 Aptinyx announced the closing of its initial public offering of 7,359,998 shares of common stock at a public offering price of $16.00 per share.
Chief Financial Officer and Chief Business Officer Ashish Khanna bought 7,800 shares on June 25 at a price of $16. The price of the stock has increased by 26.38% since.
10% Owner New Leaf Venture Management II bought 250,000 shares on June 25 at a price of $16. The price of the stock has increased by 26.38% since.
10% Owner Frazier Life Sciences VIII bought 150,000 shares on June 25 at a price of $16. The price of the stock has increased by 26.38% since.
Director Robert J. Hombach bought 24,100 shares on June 25 at a price of $16. The price of the stock has increased by 26.38% since.
10% Owner Longitude Capital Partners II bought 150,000 shares on June 25 at a price of $16. The price of the stock has increased by 26.38% since.
Director and 10% Owner James N. Topper bought 150,000 shares on June 25 at a price of $16. The price of the stock has increased by 26.38% since.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
